PTH and hypoparathyroidism: Likewise, there were no statistically significant differences at baseline between treatment groups regarding age, sex, body mass index, duration of hypoparathyroidism, etiology, albumin-corrected serum calcium level, PTH levels, and SF-36 PCS and MCS.